Fibroblasts persist within fibrotic scar tissue and exhibit considerable phenotypic and functional plasticity. Herein, we hypothesized that scar-associated fibroblasts may be a source of stressinduced inflammatory exacerbations and pain. To test this idea, we used a human model of surgery-induced fibrosis, total knee arthroplasty (TKA). Using a combination of tissue protein expression profiling and bioinformatics, we discovered that many months after TKA, the fibrotic joint exists in a state of unresolved chronic inflammation. Moreover, the infrapatellar fat pad, a soft tissue that becomes highly fibrotic in the post-TKA joint, expresses multiple inflammatory mediators, including the monocyte chemoattractant, chemokine (C-C motif) ligand (CCL) 2, and the innate immune trigger, IL-1a. Fibroblasts isolated from the post-TKA fibrotic infrapatellar fat pad express the IL-1 receptor and on exposure to IL-1a polarize to a highly inflammatory state that enables them to stimulate the recruitment of monocytes. Blockade of fibroblast CCL2 or its transcriptional regulator NF-kB prevented IL-1aeinduced monocyte recruitment. Clinical investigations discovered that levels of patient-reported pain in the post-TKA joint correlated with concentrations of CCL2 in the joint tissue, such that the chemokine is effectively a pain biomarker in the TKA patient. We propose that an IL-1aeNF-kBeCCL2 signaling pathway, operating within scar-associated fibroblasts, may be therapeutically manipulated for alleviating inflammation and pain in fibrotic joints and other tissues. (Am J Pathol 2018, 188: 696e714; https://doi.org/ 10.1016/j.ajpath. 2017.11.007) Fibrosis is the excessive deposition of scar tissue arising within a tissue or joint after injury or trauma. 1 Adhesions are fibrous bands that are generated after surgery; they form physical connections between tissues that are not normally directly connected, resulting in derangement and loss of function of the affected tissue or joint. 2 Fibrous adhesions can also be associated with intermittent periods of acute inflammation, debilitating pain, and progressive degeneration of the affected tissue or joint. 3 Therapeutic modulation of these acute exacerbations is limited by our current poor understanding of their underlying molecular triggers and mediators.
The cell type responsible for the deposition of fibrotic extracellular matrix is the fibroblast. 4, 5 After tissue damage, resident pericytes, fibroblasts, or epithelial cells transdifferentiate to the fibroblast phenotype characterized by their expression of a-smooth muscle actin and abundant secretion of collagens. 6 Resolution of wound healing is associated with the clearance of fibroblasts, whereas the maintenance and progression of fibrosis is associated with fibroblast proliferation and survival. 7 Fibroblasts exhibit considerable phenotypic plasticity and may even reverse transdifferention or alternatively adopt an inactivated state characterized by reduced secretion of extracellular matrix proteins and an extended lifespan of several weeks. 8, 9 An often underappreciated feature of fibroblasts is their ability to adopt an immune effector phenotype in response to stimulation with IL-1a/b or tumor necrosis factor-a. 10e13 We recently described how epithelial stress, via release of IL-1a, triggers the polarization of lung fibroblasts toward a proinflammatory phenotype characterized by their highly abundant secretion of IL-6, IL-8, chemokine (C-C motif) ligand (CCL) 2 (monocyte chemoattractant protein-1), and granulocyte-macrophage colony-stimulating factor. 14, 15 Similar inflammatory cytokine release has also been described in hepatic stellate cells, 16 cardiac fibroblasts, 17 dermal fibroblasts, 18 and fibroblasts isolated from the knee, 19 suggesting the ability to adopt an immunomodulatory state may be a ubiquitous property of fibroblasts. Herein, we hypothesized that fibroblasts persisting within fibrotic microenvironments may be a source of stressinduced inflammatory exacerbations and pain.
To test this hypothesis, we used a human model of surgeryinduced fibrosis, the post-surgical knee. Total knee arthroplasty (TKA) is a proven cost-effective treatment for painful end-stage knee osteoarthritis, in which the articulating joint surfaces are removed and replaced with new prostheticbearing surfaces. 20, 21 After surgery, the TKA knee is characterized by a fibrotic process, the persistence of fibroblasts lasting months after surgery, and the deposition of vast quantities of fibrotic extracellular matrix. 22, 23 Furthermore, approximately 20% of TKA patients report swelling and pain of their joint that can be more severe than that experienced before surgery. 24, 25 By acquiring synovial fluid and tissue from patients undergoing primary TKA (nonfibrotic) and patients undergoing revision TKA (fibrotic), we were able to define the inflammatory profile of the fibrotic joint and a role for IL-1 receptor (IL-1R1), expressing inflammatory fibroblasts. Using a combination of bioinformatics and in vitro assays, we provide evidence that inflammatory fibroblasts regulate monocyte recruitment to fibrotic tissues via the release of CCL2 and demonstrate that CCL2 levels in the post-TKA joint correlate with reported pain.
Materials and Methods

Ethics
This study was performed in accordance with approval from the Newcastle and North Tyneside Local Regional Ethics Committee, and informed written consent was obtained from all patients (12/NE/0395). Samples used in this research were obtained from the Newcastle Biomedicine Biobank (Newcastle upon Tyne, UK; http://www.ncl.ac.uk/ nbb/collections).
Tissue Collection and Patient Stratification
All patients undergoing revision surgery for failed primary TKA were included in the study during a 2-year period, with infection being the only exclusion criterion. Synovial fluid, infrapatellar fat pad, and synovial membrane (suprapatellar pouch) were collected from patients undergoing either primary (n Z 29) or revision (n Z 33) TKA at the Freeman Hospital (Newcastle upon Tyne, UK) ( Table 1) .
Revision TKA patients were stratified as those with osteolysis and loose components (n Z 11), a clinical diagnosis of fibrosis with loss of movement (n Z 11), primary laxity pattern with functional instability (n Z 8, of which n Z 6 had lost posterior cruciate ligamenterequired 
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For the purposes of our study, we used a definition of primary joint fibrosis as previously described. 22, 26 In all primary and revision TKA patients, local anesthetic was administered intraoperatively under direct vision (to a maximum dose of 100 mL of 0.2% ropivacaine). All patients were given routine postoperative analgesia, including regular paracetamol and a patient-controlled analgesia device. In addition, patients with restricted range of motion (fibrotic revisions) underwent continuous passive movement for 48 to 72 hours postoperatively.
Routine practice in our unit includes excision of the infrapatellar fat pad. All primary patients in the study had their infrapatellar fat pad removed. In the revision cohort, 24 had primary surgery performed in our unit and, therefore, had their infrapatellar fat pad removed in the primary procedure. The remaining nine revision patients had surgery elsewhere, and we do not know whether the infrapatellar fat pad was removed in their primary procedure. The infrapatellar fat pad tissue resected in revision surgery was from an anatomically matched site to the normal fat pad tissue found in the primary knee and resected in primary replacement surgery.
Synovial fluid was collected by aspirating fluid from the knee during surgery. The sample was sterile filtered (0.4 mm thick) and stored at À80 C. Representative tissue biopsy specimens from infrapatellar fat pad and synovial membrane were fixed in formalin and paraffin embedded. Serial tissue sections (5 mm thick) were cut and processed for staining, as described later. Tissue was homogenized in radioimmunoprecipitation assay buffer supplemented with protease and phosphatase inhibitors using a bead homogenizer (TissueLyserII; Qiagen, Hilden, Germany). Homogenized samples were normalized to 1 mg/mL total protein (protein concentration measured using a bicinchoninic acid protein assay; Pierce, Waltham, MA), as per manufacturer's instructions, and stored at À80 C
Exclusion of Infection
Preoperative workup included C-reactive protein (all patients) and joint aspiration (7 of 33 revision patients). Joint aspiration was performed only when the treating clinician believed that infection needed to be excluded. C-reactive protein was <30 in all revision patients, and all preoperative joint aspiration samples were negative after extended culture. Infection was definitively ruled out in all revision patients by microbiological analysis of synovial fluid and of multiple tissue samples taken at revision surgery. All revision patients had negative extended culture of both intraoperative synovial fluid and tissue samples. A minimum of three and a maximum of six tissue samples were taken intraoperatively, according to prosthetic joint infection guidelines. 27 As is standard practice, all orthopedic theater samples underwent extended enrichment culture for 10 days. However, a role for organisms, such as Propionibacterium acnes, that are challenging to culture, and may be an underrecognized cause of knee prosthetic joint infection, cannot be ruled out. 28, 29 Histological Analysis of Tissue Samples Formal histology reports were available for 9 of 33 revision patients. All reports state that dense, hypocellular, heavily collagenized fibrous tissue foreign body giant cells containing small transparent, strongly birefringent foreign particles were identified. The appearances are those of extensive fibrosis together with a focal giant cell reaction to foreign material, a reaction to polyethylene debris from the prosthetic joint implant. There was no evidence of infection reported in any cases.
Immunohistochemistry
Tissue sections (5 mm thick) were deparaffinized in xylene, rehydrated in graded alcohol, and incubated in 0.6% hydrogen peroxide/methanol for 15 minutes. Antigen retrieval was performed using 20 mg/mL Proteinase K (Sigma) in phosphate-buffered saline (PBS) at 37 C for 30 minutes. Blocking was performed using Avidin/Biotin Block (Vector Laboratories, Burlingame, CA), followed by porcine serum. Primary antibody incubation was performed overnight at 4 C using rabbit polyclonal primary antibody against IL-1R1 (Ab106278; Abcam, Cambridge, UK). Slides were washed with PBS and incubated with anti-rabbit biotinylated antibody (0.51 mg/L; Dako, Santa Clara, CA) in 1% porcine serum for 1 hour at room temperature. ABC tertiary (Vector Laboratories) was then applied to slides for 45 minutes at room temperature before application of 3,3 0 -diaminobenzidine mix (Vector Laboratories) for 5 minutes, followed by counterstaining with Mayer's hematoxoylin (Sigma). Slides were dehydrated in graded ethanol and Clearene (Leica Biosystems, Wetzlar, Germany) before mounting using Pertex (CellPath Ltd., Newtown Powys, UK). Images were acquired using a Nikon Eclipse Upright Microscope (Nikon Instruments Europe BV, Amsterdam, the Netherlands). For CD68 image quantification, the mean number of positive cells in Â10 randomly selected highpowered fields (Â20 magnification) was calculated using Nikon NIS elements image analysis software version 4.0 (Nikon Instruments Europe BV).
Immunocytochemistry
Tissue sections (5 mm thick) were deparaffinized in xylene and rehydrated in graded alcohol. Antigen retrieval was performed with proteinase K (20 mg/mL in PBS) for 30 minutes at 37 C. Samples were blocked with 5% bovine serum albumin/PBS and incubated overnight at 4 C with primary antibodies diluted in 5% bovine serum albumin/ PBS [IL-1R1, ab106278 (Abcam, Cambridge UK); IL-6, AF-206 at 10 mg/mL (R&D Systems, Minneapolis, MN); vimentin, M7020 at 62 mg/mL (Dako)]. Slides were washed with PBS-Tween (0.05%) and incubated with anti-rabbit tetrarhodamine isothiocyanate (T6778; SigmaAldrich) and anti-mouse fluorescein isothiocyanate (F2012; Sigma-Aldrich) diluted in 5% bovine serum albumin/PBS for 1 hour at room temperature. Slides were washed with PBS-Tween and mounted using mounting medium with DAPI (H1200; Vector Laboratories). Images were acquired on a Nikon A1R point scanning confocal microscope.
Multiarray Protein Assays
Synovial fluid (primary, n Z 21; revision, n Z 24) and tissue homogenates from infrapatellar fat pad (primary, n Z 28 patients; revision, n Z 32 patients) and synovial membrane (primary, n Z 29 patients; revision, n Z 32 patients) were assessed for expression of 39 protein markers using a human V-Plex electrochemiluminescence detection kit (K15209D; MesoScaleDiscovery, Rockville, MD), as per manufacturer's instructions. Analysis of results was performed using the MSD Discovery Workbench software version 4.0 (MesoScaleDiscovery, Rockville, MD).
Network Reconstruction
To identify potentially important intracellular signaling pathways/processes likely occurring in the revision TKA knee, we constructed a network using protein-protein interactions from InnateDB (http://www.innatedb.com). The differentially expressed markers and log(fold changes) were uploaded to the web server NetworkAnalyst (http:// www.networkanalyst.ca), 30 and the network was built with direct interactions only from the innate DB interactome. 31 The resulting network contains 730 nodes and 921 edges and was visualized with Cytoscape. 32 Statistics, such as degree (number of connections of a given node) and betweenness centrality (the number of paths between other nodes passing through a given node), were calculated. Modules (highly connected subnetworks) were found by a method based on the spreading rate of a random walk on the network. Significant gene ontology terms were identified using overrepresentation of the proteins in the network, or modules of the network, among gene sets annotated with these terms.
Fibroblast Isolation
Infrapatellar fat pad isolated from patients undergoing primary and revision TKA was homogenized and digested in 10 mL of supplement-free medium [Dulbecco's modified Eagle's medium (DMEM); D5671; Sigma] containing 100 units/mL of collagenase (C6885; Sigma) for 60 minutes. Digested tissue was passed through a 100-mm filter, and the collagenase was neutralized with complete medium (DMEM plus 10% fetal calf serum, 100 mg/mL streptomycin, 100 U/mL penicillin, and 1% L-glutamate). Cells were pelleted and resuspended in complete medium before transferring into T-75 flasks. Cells were cultured at 37 C and 5% CO 2 until >90% confluent. Cells were cryopreserved at passage number (P)0 or passaged and cryopreserved at P1. Mesenchymal phenotype was confirmed, as previously described. 19 Fibroblasts were reanimated and used between P2 and P5 for all experiments in this study.
Cell Treatments
Fibroblasts isolated from the infrapatellar fat pad of patients undergoing primary (n Z 6 patients) or revision (n Z 6 patients) TKA were serum starved for 24 hours before treatment with 0% fetal bovine serum (FBS) DMEM (control), 0% FBS DMEM þ IL-1a (500 pg/mL), or 0% FBS DMEM þ transforming growth factor (TGF)-b1 (3 ng/mL) for 24 hours. In some experiments, fibroblasts were pretreated with inhibitors [SP600125, SD1008, FR180204, SB203580, (5Z)-7-oxozeaenol, IL-1 receptor associated kinase 1/4 inhibitor 1 (all from Tocris, Minneapolis, MN) or Ik B kinase (IKK)-2 inhibitor VIII (MerckMillipore, Billerica, MA)] for 1 hour before treatment with inhibitors þ IL-1a (500 pg/mL). After 24 hours, the medium was collected, spun at 800 Â g to clear, and stored at À80 C for analysis or use in transwell migration assays.
Enzyme-Linked Immunosorbent Assay
IL-6, IL-8, and CCL2 protein levels in media samples from fibroblasts were quantified by ELISA (R&D Systems), as per manufacturer's instructions.
Lactate Dehydrogenase Assay
Lactate dehydrogenase levels in media collected from fibroblasts were quantified using a Pierce LDH Cytotoxicity Assay Kit (Thermo Scientific, Waltham, MA), as per manufacturer's protocol.
THP-1 Cell
THP-1 cells are an acute monocytic leukemia human cell line and were purchased from ATCC (TIB-202; ATCC, Manassas, VA). Cells were cultured in RPMI-1640 media (R0883; Sigma) supplemented with 10% FBS, 1% L-glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin. Cells were maintained at approximately 0.5 Â 10 6 cells/mL,
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Transwell Migration Assay
Media from fibroblasts treated with 0% FBS DMEM (control), 0% FBS DMEM þ IL-1a (500 pg/mL), 0% FBS DMEM þ TGF-b1 (3 ng/mL), or fibroblasts pretreated with inhibitors before treatment with 0% FBS DMEM þ IL-1a were placed directly into the bottom of a 24-well plate. Recombinant CCL2 (100 pg/mL) in 0% FBS DMEM was used as a positive control, and 0% FBS DMEM was used as a negative control. THP-1 cells (50,000 in 100 mL 0% FBS DMEM) were added to a 6.5-mm, 5-mm pore transwell insert (Costar Corning, Corning, NY), and the insert was added to the 24-well plate. After 18 hours, migrated cells were imaged using a Nikon D5000 camera and quantified using ImageJ software version 1.41 (NIH, Bethesda, MD; http://imagej.nih.gov/ij). In some experiments, medium from fibroblasts treated with 0% FBS DMEM þ IL-1a (500 pg/mL) was pretreated with neutralizing antibodies against CCL2 (4 mg/mL; AF-479; R&D Systems) and IL-6 (200 mg/mL; Ab6672; Abcam) for 1 hour before adding to the 24-well plate.
Clustering and Stratification
In the clustering analysis, protein expression values were transformed according to log10(intensity þ 2*d), where d is The measured markers were then sorted by fold change between primary and revision, and the top n values were used for clustering, where n was chosen so that (n þ 1) is the first not significantly DE between the two groups or where this would lead to few proteins, n Z 10. The distance measure between marker sets was the euclidean distance between the logtransformed expression, and Ward's method was used for hierarchical clustering. Heat maps were generated with the ComplexHeatmap package in R version 3.2.3 (The R Foundation for Statistical Computing, Vienna, Austria). For display, each row is Z transformed to equalize differences in overall expression. Principal component analysis was performed using the base R function princomp and all markers.
Stratification with a Reduced Set of Markers
A reduced set of markers was selected with the R package glmnet (http://www.jstatsoft.org/v33/i01). 33 The binomial family was used for the generalized linear model, with CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; NA, not applicable; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor.
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Statistical Analysis
Markers in synovial fluid, synovial membrane, and infrapatellar fat pat were grouped into those significantly elevated, those significantly decreased, and those not significantly different or undetectable in patients undergoing primary and revision TKA. Data are presented as a Venn diagram, graphically as change in median expression levels, as box-and-whiskers plots for individual CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; NA, not applicable; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor. markers, and in tabular form. Significance was calculated using U-test. Correlations between IL-1a levels and CCL2, IL-6, and IL-8 levels were tested using linear regression. In vitro data are presented as means AE SEM. Differences between treatment groups were analyzed using paired t-test (Graphpad Prism 6; GraphPad Software Inc., La Jolla, CA). Significance was set at P < 0.05.
Results
Chronic Inflammation Is a Common Feature of the Postsurgical Joint
The post-TKA joint is associated with the persistence of fibroblasts and extensive fibrotic remodeling of the replacement joint ( Figure 1A) . 22, 35 To determine the degree to which TKA CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; NA, not applicable; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TKA, total knee arthroplasty; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor.
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The American Journal of Pathology -ajp.amjpathol.orgis associated with inflammation, synovial fluid, synovial membrane, and infrapatellar fat pad were collected from patients undergoing primary or revision surgery and the expression of 39 soluble inflammatory proteins was profiled at each anatomical location. When comparing protein expression between pre-and post-TKA samples, it was discovered that all three anatomical locations in the fibrotic joint display an enhanced proinflammatory state (Tables 2, 3 , and 4, Figure 2, and Supplemental Figures S1, S2, and S3). Synovial fluid was the most dramatically affected, with elevated expression of 26 inflammatory markers, followed by the infrapatellar fat pad (22 up-regulated proteins) and the synovial membrane (10 upregulated proteins). These data were used to construct a Venn diagram ( Figure 1B) illustrating the anatomical location of the up-regulated inflammatory markers. CCL2, CCL3 (MIP-1a), CCL4 (MIP-1b), CCL17 (TARC), CCL22 (MDC), Figure 2 Markers of inflammation are elevated in patients undergoing revision total knee arthroplasty (TKA). Fold change in protein expression in synovial fluid (A), infrapatellar fat pad (B), and synovial membrane (C) isolated from patients undergoing revision TKA compared with patients undergoing primary TKA. Fold change was calculated using median protein expression. Significance was calculated using U-test. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 primary versus revision patients. CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocytemacrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor. ajp.amjpathol.org -The American Journal of Pathology IL-8, IP-10, IL-23p40, and tumor necrosis factor-a were upregulated in all three regions of the fibrotic joint. By far the most induced protein was IL-8, which was expressed at approximately 35-fold, approximately 40-fold, and approximately 80-fold higher levels in the synovial fluid, infrapatellar fat pad, and synovial membrane, respectively (Figure 2 ). The synovial fluid was the most proinflammatory, with eight proteins exclusively elevated in revision TKA compared with primary TKA. These proteins were the granulocyte recruitment ligands CCL13 (monocyte chemoattractant protein-4) and CCL26 (eotaxin-3), the granulocyte modulator granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-b, the cleaved form of vascular cell adhesion molecule 1, and proangiogenic factors vascular endothelial growth factor-C and Fms-like tyrosine kinase 1 ( Figure 1B) . Together, these markers suggest the synovial fluid of the fibrotic joint resembled a state of chronic allergic inflammation. 36 Up-regulated T-cell stimulators IL-2, IL-15, and IL-16, the inflammatory cytokines IL-1a, IL-1b, and IL-5, and the cleaved form of intercellular adhesion molecule 1 were common to the synovial fluid and infrapatellar fat pad of the fibrotic joint.
Fibroblasts from the Infrapatellar Fat Pad Polarize to a Proinflammatory Phenotype in Response to IL-1a
Having established that the fibrotic post-TKA joint acquires a state of unresolved inflammation, it was next determined if fibroblasts contribute to this state. We previously reported that the infrapatellar fat pad is a site at which extensive fibrotic remodeling and fibroblast accumulation occur after TKA. 22 Furthermore, we now demonstrate that fibroblasts in the post-TKA joint express IL-1R1 ( Figure 1A ). IL-1a polarizes fibroblasts toward a proinflammatory state 19 and is elevated in both the post-TKA infrapatellar fat pad and synovial fluid ( Figure 1B) . Fibroblasts isolated from the infrapatellar fat pad and exposed to pg/mL levels of IL-1a underwent a dramatic induction of CCL2, IL-6, and IL-8, all being secreted at ng/mL levels. By contrast, profibrogenic TGF-b1 failed to induce this proinflammatory state ( Figure 3A ). IL-6 was remarkable in that it was a unique inflammatory feature of the infrapatellar fat pad in the post-TKA joint ( Figure 1B) . Multiarray protein measurements confirmed that IL-6 is up-regulated in the remodeled infrapatellar fat pad, but remains unchanged in the synovial fluid ( Figure 3, B and C) . Moreover, elevated IL-1a in the fibrotic infrapatellar fat pad (pg/mL levels) correlated with enhanced expression of CCL2, IL-6, and IL-8 ( Figure 3D ), suggesting that fibroblasts exposed to IL-1a in the microenvironment of the fibrotic infrapatellar fat pad are likely to be a major source of proinflammatory CCL2, IL-6, and IL-8. In agreement with this, immunocytochemistry performed on the post-TKA infrapatellar fat pad identified a significant number of the vimentinpositive fibroblasts that were also positive for IL-6 ( Figure 1C) .
To determine intracellular signaling pathways responsible for mediating IL-1aeinduced polarization of fibroblasts, the cells were treated with inhibitors of downstream signal transduction molecules. Inhibitors of Janus activating kinase 2, transforming growth factor beactivated kinase 1 (TAK1), and IKK-2, signaling molecules known to activate the cardinal proinflammatory transcription factor NF-kB, 37e39 blunted IL-1aeinduced expression of CCL2 by twofold or greater ( Figure 3 , E and F, and Supplemental Figure S4) .
To investigate the in vivo relevance of these data, a systems bioinformatics analysis was performed using the protein expression data derived from the multiarray protein measurements of up-regulated proinflammatory molecules in synovial fluid of the post-TKA joint (Table 2 and Figure 1B) . By using a network reconstruction technique, the innate immune protein interactome of the remodeled TKA joint was interrogated (Figure 4 ). Of particular note was the mapping of NF-kB family proteins Rel (c-Rel), RelA (p65), RelB, and NF-kB1 (p50) in a network including CCL17, IP-10, CCL2, CCL22, CCL3, CCL4, CCL11 (eotaxin), and IL-15, all of which were identified as up-regulated in one or both of the synovial fluid and infrapatellar fat pad of the fibrotic post-TKA joint ( Figure 4A ). The reconstructed network also contained TAK1, IKK-2, and the Janus activating kinase 2 target STAT3, rationalizing their role in the CCL2 response to IL-1a. Proteins in the network and in highly connected submodules were also enriched for gene ontology processes, including leukocyte migration and response to wound healing ( Figure 4B ).
Inflammatory Fibroblasts Regulate Monocyte Recruitment via NF-kBeRegulated Expression of CCL2
Having established that IL-1a polarizes fibroblasts toward an inflammatory phenotype, it was next tested if these cells are able to directly stimulate recruitment of immune cells, specifically monocytes. To test this hypothesis, a transwell migration assay was performed with human THP-1 monocytes and conditioned media from unstimulated, IL-1aestimulated, or TGF-b1estimulated fibroblasts. Conditioned media from IL-1aestimulated fibroblasts significantly increased migration of monocytes compared with unstimulated cells. TGF-b1 treatment had no effect on monocyte migration ( Figure 5A ). Pretreating the conditioned media with neutralizing antibodies against CCL2 and IL-6 identified CCL2 as the predominant mediator of monocyte recruitment, such that anti-CCL2 reduced monocyte recruitment by approximately 80%; in contrast, antieIL-6 had negligible effects ( Figure 5B ). Treatment of IL-1aestimulated fibroblasts with inhibitors of Janus activating kinase 2, TAK1, and IKK effectively prevented their ability to recruit monocytes, confirming the requirement of NF-kB activation ( Figure 5C ). Because CCL2 was found to be significantly elevated in the post-TKA synovial fluid and infrapatellar fat pad and is integrated with NF-kB in the innate immune interactome of the fibrotic joint, CD68 þ monocytes in the fibrotic joint were quantified. There was a significant increase in the number of CD68 þ monocytes in the infrapatellar fat pad of fibrotic revision post-TKA joints compared with nonfibrotic primary TKA joints ( Figure 5D ).
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Elevated CCL2 in the Inflammatory Environment of the Fibrotic Post-TKA Joint Correlates with Pain
The degree to which the inflammatory profile of the synovial fluid of the joint stratifies patients into those requiring revision TKA surgery was quantified. Inflammatory proteins with the greatest fold change between primary and revision patients were log transformed and used for hierarchical clustering, which was visualized by a heat map. The use of inflammatory protein expression in the synovial fluid was sufficient to segregate revision from primary TKA patients with only n Z 1 revision and n Z 2 primary TKA patients misclassified ( Figure 6A ). The predictive value of the inflammatory profile of the infrapatellar fat pad (Supplemental Figure S5A ) and the synovial membrane (Supplemental Figure S6A ) was also assessed. Although a degree of stratification was observed with these tissues, there was a larger degree of overlap between the patient groups compared with synovial fluid. Principal component analysis was performed to further investigate the predictive value of the inflammatory profile in the synovial fluid ( Figure 6B ). This approach demonstrated the excellent predictive value of the synovial fluid, with distinct separation of primary and revision TKA samples (only n Z 1 revision TKA patient clustering incorrectly). Similar analysis of the infrapatellar fat pad (Supplemental Figure S5B ) and synovial membrane (Supplemental Figure S6B) again demonstrated a much larger degree of overlap compared with synovial fluid. The R package glmnet was used to select a reduced set of inflammatory markers that reliably classify primary and revision TKA patients. Again, the synovial fluid had the most predictive value and indicated that a single inflammatory marker, CCL2, achieved a misclassification error of <5% ( Figure 6C ). Indeed, using CCL2 alone to generate a receiver operating characteristic curve achieved an area under the curve of 96.8% (95% CI, 89%e100%) in stratifying patients as primary or revision TKA ( Figure 6D ). The misclassification error was significantly higher for the infrapatellar fat pad (Supplemental Figure S5C ) and synovial membrane (Supplemental Figure S6C) , whereas the ability of CCL2 alone to stratify patients was also reduced (infrapatellar fat pad: area under the curve, 84.2%; 95% CI, 74%e95%) (Supplemental Figure S5D ) (synovial membrane: area under the curve, 76.9%; 95% CI, 65%e89%) (Supplemental Figure S6D) . For these tissues, glmnet analysis suggested that more complex models containing additional markers, such as CCL3, CCL13, CCL22, IL-8, and C-reactive protein, may be better able to stratify patients, but would still not match the accuracy of CCL2 in synovial fluid (Supplemental Figures S5C and S6C) .
Because degree of pain and stiffness are clinical measures of success of the post-TKA joint and patient quality of life, 25 the degree to which these clinical outcomes correlated with inflammatory markers in the joint was determined. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores for pain and stiffness were obtained from the Newcastle Freeman Joint Registry for patients consented to this study and correlated to levels of CCL2 and other markers significantly elevated in post-TKA patients. A significant correlation between CCL2 levels in synovial fluid and WOMAC pain scores was observed, but no correlation with WOMAC stiffness scores was found ( Figure 7) . A significant positive correlation was also seen with vascular endothelial growth factor-C and other markers elevated after TKA, such as IL-8, CCL22, CCL3, and tumor necrosis factor-a; these markers also demonstrated a nonstatistically significant correlation with WOMAC pain scores. Again, there was little to no correlation between any of the markers and WOMAC stiffness scores. Interestingly, levels of CCL2, IL-8, CCL22, and CCL3 in the infrapatellar fat pad were significantly correlated with WOMAC stiffness scores but not with WOMAC pain scores (Supplemental Figure S7) . Levels of marker expression did not significantly correlate with either WOMAC pain or stiffness scores in synovial membrane (Supplemental Figure S8) .
We conclude that inflammatory markers in the post-TKA synovial fluid correlate with pain and that CCL2, a factor produced by inflammatory fibroblasts in the fibrotic joint, is sufficient to predict pain and identify patients requiring revision TKA surgery.
Discussion
Modern lower limb arthroplasty results in pain relief and satisfactory outcomes in >80% of patients. However, as many as 20% of patients express post-surgical dissatisfaction because of persistent pain, swelling, loss of movement, and reduced functional ability in the absence of joint Figure 3 Markers elevated after total knee arthroplasty (TKA) are associated with fibroblast activation. A: Fibroblasts isolated from the infrapatellar fat pad of patients undergoing primary TKA were treated with control media, IL-1a (500 pg/mL), or transforming growth factor (TGF)-b1 (3 ng/mL) for 24 hours and secreted levels of CCL2, IL-6, and IL-8, determined by enzyme-linked immunosorbent assay (ELISA). Data are analyzed using paired t-tests. B and C: IL-1a, CCL2, IL-6, and IL-8 protein levels were quantified in synovial fluid (B) and infrapatellar fat pad (C) and compared between patients undergoing primary and revision TKA. Data are presented as individual patient values, with median signified by the red line and analyzed using a U-test. D: IL-1a protein expression correlates against CCL2, IL-6, and IL-8 levels in synovial fluid. Data are presented as individual patient values with associated linear regression analysis. E and F: Fibroblasts isolated from the infrapatellar fat pad of patients undergoing primary (E) and revision (F) TKA were pretreated for 1 hour with several selective inhibitors [TAK1 inhibitor (TAK i ), 1 mmol/L; all other inhibitors, 10 mmol/L] before stimulation with IL-1a (500 pg/mL) for 24 hours, and CCL2 was quantified by ELISA. Data are analyzed using paired t-tests. Data are presented as means AE SEM (A, E, and F). n Z 6 (A, E, and F). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 primary versus revision patients. ERK, extracellular signaleregulated kinase; IKK, Ik B kinase; IRAK, IL-1 receptor associated kinase; JAK, Janus activating kinase; JNK, c-Jun N-terminal kinase; MCP, monocyte chemoattractant protein.
Fibroblasts Drive Inflammation and Pain
The American Journal of Pathology -ajp.amjpathol.orginstability or infection. 25 The epidemiology and etiology of this postoperative state remain poorly understood, in particular with respect to pain, yet the symptoms are often sufficiently severe to necessitate early revision surgery, within 5 years of the primary operation. The aim of this study was to determine the nature of the inflammatory process occurring in joints requiring revision surgery and to interrogate the potential role of the fibroblast to contribute to stress-induced inflammatory exacerbations and pain in the post-TKA knee. Extensive fibrotic remodeling is found to be common to revised TKA joints and is characterized by the accumulation of fibrotic extracellular matrix into the infrapatellar fat pad and synovial membrane. 22 The fibrotic matrix of the TKA joint is also characterized by the persistence of high numbers of a-smooth muscle actine and IL-1R1epositive fibroblasts.
19,35 Herein, we discovered that the fibrotic post-TKA knee is characterized by a chronic inflammatory signature and identify IL-1R1epositive fibroblasts as a potential source of proinflammatory mediators that promote monocyte recruitment and pain in the TKA joint. This occurs via a paracrine pathway in which soluble IL-1a stimulates NF-kBedependent expression of CCL2. This illuminates a new disease model in which nonresolving fibrosis becomes a driver of inflammation in response to the sterile innate immune triggers (IL-1a). This model has potential relevance to the pathophysiology of all active fibrotic tissues and may help explain the poorly understood association of fibrosis with inflammatory flares and chronic pain in osteoarthritic (OA) joints. We further propose that targeting the fibroblast in the setting of the fibrotic joint offers a novel and rationale approach for suppressing inflammation and pain (ie, worthy of further investigation).
Our key findings are as follows: i) the synovial fluid and infrapatellar fat pad of painful TKA joints displayed elevated expression of multiple inflammatory proteins, including IL-1a and CCL2; ii) bioinformatics analyses of soluble protein expression in the inflamed joint indicated convergence on NF-kB signaling, indicative of a state of chronic unresolved inflammation; iii) fibroblasts in the fibrotic infrapatellar fat pad express IL-1R1 and IL-6 in vivo and in response to IL-1a, polarized toward a highly inflammatory phenotype characterized by induction of CCL2 in vitro; and iv) CCL2 levels in the joint closely correlated with the degree of pain. From a translational perspective, the main strength of this study is that it identified the association of IL-1a/NF-kB/CCL2 inflammatory signaling in fibroblasts as a driver of inflammation and pain using directly relevant human TKA tissues. Furthermore, this novel pathway offers multiple points for therapeutic intervention using drugs that are safe and clinically effective in humans. A limitation of the study is the limited information available on the revision patients referred into our unit for specialist treatment. Specifically, we do not know whether all of the revision patients had their infrapatellar fat pad excised during their primary surgery and the extent of the synovial resection initially Figure 5 IL-1aeactivated fibroblasts promote recruitment of monocytes by secreting CCL2. Fibroblasts isolated from the infrapatellar fat pad of patients undergoing primary total knee arthroplasty (TKA) were stimulated with control media, IL-1a (500 pg/mL), or transforming growth factor (TGF)-b1 (3 ng/mL) for 24 hours to generate conditioned media for transwell migration assays. A: Number of monocytes recruited by conditioned media from unstimulated (control), IL-1ae stimulated, and TGF-b1estimulated fibroblasts. B: Conditioned medium from IL-1aestimulated fibroblasts was pretreated for 1 hour with neutralizing antibodies against CCL2 and IL-6 and then used in transwell migration assays. C: Conditioned medium from fibroblasts pretreated for 1 hour with several selective inhibitors (transforming growth factor beactivated kinase, 1 mmol/L; all other inhibitors, 10 mmol/L) before stimulation with IL1a for 24 hours and then used in transwell migration assays. The number of migrated cells was quantified on a Nikon Eclipse microscope. Data are analyzed using paired t-tests. D: Number of CD68 þ cells in the infrapatellar fat pad of patients undergoing primary and revision TKA was quantified in 10Â randomly selected high-powered fields using Nikon NIS elements image analysis software. Data are analyzed using U-test. Data are presented as means AE SEM (C and D). n Z 6 (AeC). *P < 0.05, **P < 0. 
The American Journal of Pathology -ajp.amjpathol.orgperformed. Fat pad resection has been associated with increased anterior knee pain and patella baja, which is suggestive of increased intra-articular scarring. 40, 41 Traditionally, fibroblasts are considered as structural cells that, in response to tissue damage, adopt an activated fibroblast state and promote wound healing and fibrogenesis via their secretion of fibrous collagens and inhibitors of collagenases. 4 Less well recognized is that these cells exhibit substantial heterogeneity and phenotypic plasticity and can adopt fibroblastic, contractile, or inflammatory states under the influence of cues in their microenvironment. 13 Polarization of fibroblasts to an inflammatory state is characterized by their acquired expression of IL-6 and IL-8. Studies in fibroblasts derived Figure 6 CCL2 in synovial fluid can be used to stratify patients undergoing revision total knee arthroplasty (TKA) from patients undergoing primary TKA. A:
Heat map of log-transformed protein intensity in synovial fluid isolated from patients undergoing primary or revision TKA clustered using the differentially expressed markers with the highest fold change. Asterisks indicate markers that were used for clustering analysis/stratification. B: Principal component analysis plot of all patients using all markers. C: Classification error as function of the number of markers included, cross validated using glmnet package. Dotted lines mark two important values of the regularization parameter l, which controls the number of markers included. On the left is the value of l that gives the minimum mean cross-validated error. On the right is the value that gives the most regularized model, such that error is within one SEM of the minimum. D: Receiver operating characteristic curve for classification with CCL2 alone [area under the curve (AUC), 0.968; 95% CI, 0.89e1.0]. CRP, C-reactive protein; FGF, fibroblast growth factor; Flt, Fms-like tyrosine kinase 1; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IP-10, interferon gamma-induced protein 10; PIGF, placental growth factor; SAA, serum amyloid A; Tie, tyrosine kinase; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor. ajp.amjpathol.org -The American Journal of Pathology from multiple tissues (eg, lung, intestine, heart, and skin) indicate that the innate immune trigger IL-1a is a powerful paracrine stimulator of an inflammatory polarization of their phenotype. 12, 14, 15, 17, 42 It was found to be true for fibroblasts derived from the infrapatellar fat pad, such that exposure to pg/mL levels of IL-1a induced ng/mL levels of secreted IL-6, IL-8, and CCL2. More important, IL-1R1 and IL-6 expression was located primarily to fibroblasts in the fibrotic infrapatellar fat pad, whereas soluble IL-1a, IL-6, IL-8, and CCL2 were also elevated and correlated with IL-1a levels in the infrapatellar fat pad of the TKA joint. An important future question will be to identify the cellular source of IL-1a in the joint because this information will reveal the underlying cellular damage/stress mechanisms that trigger the activation of inflammatory fibroblasts of fibrotic tissue. Potential resident sources of IL1a in the knee include macrophage-like type A and fibroblast-like type B synovial cells. 43, 44 Fibroblasts persisting in the fibrotic TKA joint express IL-1R1, indicating they are primed for polarization to an inflammatory state on exposure to IL-1a. Scarpa et al 42 reported that fibroblasts isolated from inflammatory bowel disease tissue expressed IL-1R1, as did intestinal subepithelial fibroblasts in the intestine of mice challenged with a low dose of dextran sulfate sodium. More important, after mice had recovered from this mild intestinal injury, a subsequent intrarectal administration of IL-1a induced severe colitis, whereas mice that had not undergone prior Osteoarthritis Index scores, were plotted against expression levels of several markers that were significantly elevated in the synovial fluid of patients undergoing revision total knee arthroplasty (TKA). Data are presented for patients undergoing primary and revision TKA, and correlations were determined by linear regression analysis. Increased levels of CCL2 are highly predictive of pain but are poorly correlated to stiffness. n Z 13 primary TKA group; n Z 18 revision TKA group. TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
The American Journal of Pathology -ajp.amjpathol.orgdextran sulfate sodiumeinduced tissue remodeling failed to mount an inflammatory response to IL-1a. The appearance of IL-1R1epositive fibroblasts, therefore, appears to constitute a tissue memory of previous damage that primes the tissue for a robust inflammatory flare when these cells engage IL-1a in the microenvironment. This concept challenges the traditional simple linear model of fibrogenesis in which inflammation is the driver of fibrosis. Instead, we propose a dynamic positive feed-forward process in which inflammatory fibroblasts sense local tissue damage and, via release of CCL2 and other chemokines, promote the recruitment and activation of innate immune cells to drive inflammation; this process constitutes a circulus vitiosus.
CCL2 classically operates as a chemoattractant for monocytes by binding to its receptor CCR2. 45, 46 CCL2 is highly expressed in the synovial fluid of OA joints and knees after trauma and, as observed herein, is a feature of the inflammatory synovium and infrapatellar fat pad of the fibrotic TKA joint. 47e50 Although no data directly demonstrating that CCL2 is driving the recruitment of monocytes in vivo have been presented, we hypothesize that the elevated levels of CCL2 in the post-TKA knee are likely one of the factors contributing to the recruitment of CD68 þ cells in a similar manner to what has recently been reported in OA. 51 An unexpected and novel finding was the close correlation between levels of CCL2 in the synovial fluid of the TKA joint and reported WOMAC pain scores, although no correlation was observed between levels of CCL2 in infrapatellar fat pad and synovial membrane and reported WOMAC pain scores. Although the synovial fluid is unlikely to contain significant numbers of fibroblasts, it is highly likely that fibroblasts present within joint tissues (including the infrapatellar fat pad and synovial membrane as well as other intra-articular or periarticular tissues, such as the joint capsule) are contributing to chronic inflammation in the synovial fluid, as has been previously reported in OA. 52 In this context, it is intriguing that sensory neurons express CCR2 and, furthermore, CCL2-CCR2 engagement leads to excitation of nociceptive neurons, an event usually associated with the sensation of pain.
53e56 In a murine model of OA, genetic deletion of either CCL2 or CCR2 delayed the onset of pain-related behavior. 57 These observations warrant future studies examining the potential for the use of emerging small-molecule inhibitors of CCR2 as therapies for relieving inflammation and intractable pain in the OA and/or post-TKA joint. Alternatively, a similar outcome may be achieved by the local administration of the IL-1R1 antagonist, anakinra; indeed, there is prior clinical evidence that this approach may be beneficial in TKA. 58 Because NF-kB signaling appears to be pivotal for IL1aeinduced expression of CCL2 by fibroblasts, there may also be an analgesic benefit to be gained from the local administration of small-molecule inhibitors of NF-kB or its upstream kinase, IKK. 59, 60 Such an approach may also reduce numbers of fibroblasts in the fibrotic tissue because suppression of NF-kB in these cells is associated with the induction of apoptosis. 61 In summary, this study identified an important role for fibrosis-associated fibroblasts as sensors of cellular stress/ damage via engagement of surface-expressed IL-1R1 with the alarmin IL-1a, which leads to secretion of CCL2, a wellestablished stimulator of monocyte recruitment and nociceptive pain. We hypothesize that IL-1R1eexpressing fibroblasts persist in unresolved fibrotic tissue and prime the tissue for inflammatory episodes in response to local cell stress/damage. Finally, the inflamed post-TKA joint is an important new human disease model with which to further illuminate the complex cross talk between fibrosis, inflammation, and pain. ajp.amjpathol.org -The American Journal of Pathology
